Metformin prevents the onset and progression of intervertebral disc degeneration: New insights and potential mechanisms (Review)

Wang F, Cai F, Shi R, Wang XH and Wu XT: Aging and age related stresses: A senescence mechanism of intervertebral disc degeneration. Osteoarthritis Cartilage. 24:398–408. 2016. View Article : Google Scholar

Cornaz F, Widmer J, Farshad-Amacker NA, Spirig JM, Snedeker JG and Farshad M: Biomechanical contributions of spinal structures with different degrees of disc degeneration. Spine (Phila Pa 1976). 46:E869–E877. 2021. View Article : Google Scholar

Lan T, Shiyu H, Shen Z, Yan B and Chen J: New insights into the interplay between miRNAs and autophagy in the aging of intervertebral discs. Ageing Res Rev. 65:1012272021. View Article : Google Scholar

Risbud MV and Shapiro IM: Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nat Rev Rheumatol. 10:44–56. 2014. View Article : Google Scholar

GBD 2019 Diseases and Injuries Collaborators: Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the global burden of disease study 2019. Lancet. 396:1204–1222. 2020. View Article : Google Scholar : PubMed/NCBI

Yang Y, Lai X, Li C, Yang Y, Gu S, Hou W, Zhai L and Zhu Y: Focus on the impact of social factors and lifestyle on the disease burden of low back pain: Findings from the global burden of disease study 2019. BMC Musculoskelet Disord. 24:6792023. View Article : Google Scholar : PubMed/NCBI

Goode AP, Carey TS and Jordan JM: Low back pain and lumbar spine osteoarthritis: How are they related? Curr Rheumatol Rep. 15:3052013. View Article : Google Scholar : PubMed/NCBI

Maher C, Underwood M and Buchbinder R: Non-specific low back pain. Lancet. 389:736–747. 2017. View Article : Google Scholar

Chou R: Low back pain. Ann Intern Med. 174:ITC113–ITC128. 2021. View Article : Google Scholar : PubMed/NCBI

Apostolova N, Iannantuoni F, Gruevska A, Muntane J, Rocha M and Victor VM: Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions. Redox Biol. 34:1015172020. View Article : Google Scholar : PubMed/NCBI

Sanchez-Rangel E and Inzucchi SE: Metformin: Clinical use in type 2 diabetes. Diabetologia. 60:1586–1593. 2017. View Article : Google Scholar : PubMed/NCBI

LaMoia TE and Shulman GI: Cellular and molecular mechanisms of metformin action. Endocr Rev. 42:77–96. 2021. View Article : Google Scholar :

An H and He L: Current understanding of metformin effect on the control of hyperglycemia in diabetes. J Endocrinol. 228:R97–R106. 2016. View Article : Google Scholar : PubMed/NCBI

Foretz M, Hébrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, Sakamoto K, Andreelli F and Viollet B: Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 120:2355–2369. 2010. View Article : Google Scholar : PubMed/NCBI

Caton PW, Nayuni NK, Kieswich J, Khan NQ, Yaqoob MM and Corder R: Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. J Endocrinol. 205:97–106. 2010. View Article : Google Scholar : PubMed/NCBI

Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, et al: Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes. 57:306–314. 2008. View Article : Google Scholar

Masarwa R, Brunetti VC, Aloe S, Henderson M, Platt RW and Filion KB: Efficacy and safety of metformin for obesity: A systematic review. Pediatrics. 147:e202016102021. View Article : Google Scholar : PubMed/NCBI

Day EA, Ford RJ, Smith BK, Mohammadi-Shemirani P, Morrow MR, Gutgesell RM, Lu R, Raphenya AR, Kabiri M, McArthur AG, et al: Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat Metab. 1:1202–1208. 2019. View Article : Google Scholar

Kamarudin MNA, Sarker MMR, Zhou JR and Parhar I: Metformin in colorectal cancer: Molecular mechanism, preclinical and clinical aspects. J Exp Clin Cancer Res. 38:4912019. View Article : Google Scholar : PubMed/NCBI

Luo F, Das A, Chen J, Wu P, Li X and Fang Z: Metformin in patients with and without diabetes: A paradigm shift in cardiovascular disease management. Cardiovasc Diabetol. 18:542019. View Article : Google Scholar : PubMed/NCBI

Griffin SJ, Leaver JK and Irving GJ: Impact of metformin on cardiovascular disease: A meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia. 60:1620–1629. 2017. View Article : Google Scholar : PubMed/NCBI

Diamanti-Kandarakis E, Economou F, Palimeri S and Christakou C: Metformin in polycystic ovary syndrome. Ann N Y Acad Sci. 1205:192–198. 2010. View Article : Google Scholar : PubMed/NCBI

Song A, Zhang C and Meng X: Mechanism and application of metformin in kidney diseases: An update. Biomed Pharmacother. 138:1114542021. View Article : Google Scholar : PubMed/NCBI

Chen S, Gan D, Lin S, Zhong Y, Chen M, Zou X, Shao Z and Xiao G: Metformin in aging and aging-related diseases: Clinical applications and relevant mechanisms. Theranostics. 12:2722–2740. 2022. View Article : Google Scholar : PubMed/NCBI

Lu CH, Chung CH, Kuo FC, Chen KC, Chang CH, Kuo CC, Lee CH, Su SC, Liu JS, Lin FH, et al: Metformin attenuates osteoporosis in diabetic patients with carcinoma in situ: A nationwide, retrospective, matched-cohort study in Taiwan. J Clin Med. 9:28392020. View Article : Google Scholar : PubMed/NCBI

Li J, Zhang B, Liu WX, Lu K, Pan H, Wang T, Oh CD, Yi D, Huang J, Zhao L, et al: Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann Rheum Dis. 79:635–645. 2020. View Article : Google Scholar : PubMed/NCBI

Li X, Liu X, Wang Y, Cao F, Chen Z, Hu Z, Yu B, Feng H, Ba Z, Liu T, et al: Intervertebral disc degeneration in mice with type II diabetes induced by leptin receptor deficiency. BMC Musculoskelet Disord. 21:772020. View Article : Google Scholar : PubMed/NCBI

Cannata F, Vadalà G, Ambrosio L, Fallucca S, Napoli N, Papalia R, Pozzilli P and Denaro V: Intervertebral disc degeneration: A focus on obesity and type 2 diabetes. Diabetes Metab Res Rev. 36:e32242020. View Article : Google Scholar

Chen D, Xia D, Pan Z, Xu D, Zhou Y, Wu Y, Cai N, Tang Q, Wang C, Yan M, et al: Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. Cell Death Dis. 7:e24412016. View Article : Google Scholar : PubMed/NCBI

Liao Z, Li S, Lu S, Liu H, Li G, Ma L, Luo R, Ke W, Wang B, Xiang Q, et al: Metformin facilitates mesenchymal stem cell-derived extracellular nanovesicles release and optimizes therapeutic efficacy in intervertebral disc degeneration. Biomaterials. 274:1208502021. View Article : Google Scholar : PubMed/NCBI

Ren C, Jin C, Li C, Xiang J, Wu Y, Zhou Y, Sun L, Zhang X and Tian N: Metformin inactivates the cGAS-STING pathway through autophagy and suppresses senescence in nucleus pulposus cells. J Cell Sci. 135:jcs2597382022. View Article : Google Scholar : PubMed/NCBI

Han Y, Yuan F, Deng C, He F, Zhang Y, Shen H, Chen Z and Qian L: Metformin decreases LPS-induced inflammatory response in rabbit annulus fibrosus stem/progenitor cells by blocking HMGB1 release. Aging (Albany NY). 11:1252–10265. 2019.

Ramanathan R, Firdous A, Dong Q, Wang D, Lee J, Vo N and Sowa G: Investigation into the anti-inflammatory properties of metformin in intervertebral disc cells. JOR Spine. 5:e11972022. View Article : Google Scholar : PubMed/NCBI

Kaya YE, Karaarslan N, Yilmaz I, Sirin DY, Akalan H and Ozbek H: A study of the effects of metformin, a biguanide derivative, on annulus fibrosus and nucleus pulposus cells. Turk Neurosurg. 30:434–441. 2020.PubMed/NCBI

Stephenne X, Foretz M, Taleux N, van der Zon GC, Sokal E, Hue L, Viollet B and Guigas B: Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia. 54:3101–3110. 2011. View Article : Google Scholar : PubMed/NCBI

Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Yue Chu Y, Iyoha E, Segal JB and Bolen S: Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med. 164:740–751. 2016. View Article : Google Scholar : PubMed/NCBI

Zhang F, Zhao X, Shen H and Zhang C: Molecular mechanisms of cell death in intervertebral disc degeneration (Review). Int J Mol Med. 37:1439–1448. 2016. View Article : Google Scholar : PubMed/NCBI

Gong CY and Zhang HH: Autophagy as a potential therapeutic target in intervertebral disc degeneration. Life Sci. 273:1192662021. View Article : Google Scholar : PubMed/NCBI

Li J, Wang C, Xue L, Zhang F and Liu J: Melatonin suppresses apoptosis of nucleus pulposus cells through inhibiting autophagy via the PI3K/Akt pathway in a high-glucose culture. Biomed Res Int. 2021:46042582021.PubMed/NCBI

Humzah MD and Soames RW: Human intervertebral disc: Structure and function. Anat Rec. 220:337–356. 1988. View Article : Google Scholar : PubMed/NCBI

Bach FC, de Vries SAH, Krouwels A, Creemers LB, Ito K, Meij BP and Tryfonidou MA: The species-specific regenerative effects of notochordal cell-conditioned medium on chondrocyte-like cells derived from degenerated human intervertebral discs. Eur Cell Mater. 30:132–147. 2015. View Article : Google Scholar : PubMed/NCBI

Urban JPG and Roberts S: Degeneration of the intervertebral disc. Arthritis Res Ther. 5:120–130. 2003. View Article : Google Scholar : PubMed/NCBI

Dowdell J, Erwin M, Choma T, Vaccaro A, Iatridis J and Cho SK: Intervertebral disk degeneration and repair. Neurosurgery. 80(3S): S46–S54. 2017. View Article : Google Scholar : PubMed/NCBI

Oegema TR Jr: Biochemistry of the intervertebral disc. Clin Sports Med. 12:419–439. 1993. View Article : Google Scholar : PubMed/NCBI

Adams MA and Roughley PJ: What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976). 31:2151–2161. 2006. View Article : Google Scholar : PubMed/NCBI

Bruehlmann SB, Rattner JB, Matyas JR and Duncan NA: Regional variations in the cellular matrix of the annulus fibrosus of the intervertebral disc. J Anat. 201:159–171. 2002. View Article : Google Scholar : PubMed/NCBI

Roberts S, Menage J, Duance V, Wotton S and Ayad S: 1991 Volvo Award in basic sciences. Collagen types around the cells of the intervertebral disc and cartilage end plate: An immunolocalization study. Spine (Phila Pa 1976). 16:1030–1038. 1991. View Article : Google Scholar : PubMed/NCBI

Mwale F, Roughley P and Antoniou J: Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: A requisite for tissue engineering of intervertebral disc. Eur Cell Mater. 8:58–64. 2004. View Article : Google Scholar : PubMed/NCBI

Maroudas A, Stockwell RA, Nachemson A and Urban J: Factors involved in the nutrition of the human lumbar intervertebral disc: Cellularity and diffusion of glucose in vitro. J Anat. 120:113–130. 1975.PubMed/NCBI

Yu J, Winlove PC, Roberts S and Urban JPG: Elastic fibre organization in the intervertebral discs of the bovine tail. J Anat. 201:465–475. 2002. View Article : Google Scholar : PubMed/NCBI

Pattappa G, Li Z, Peroglio M, Wismer N, Alini M and Grad S: Diversity of intervertebral disc cells: Phenotype and function. J Anat. 221:480–496. 2012. View Article : Google Scholar : PubMed/NCBI

Moon SM, Yoder JH, Wright AC, Smith LJ, Vresilovic EJ and Elliott DM: Evaluation of intervertebral disc cartilaginous endplate structure using magnetic resonance imaging. Eur Spine J. 22:1820–1828. 2013. View Article : Google Scholar : PubMed/NCBI

Broberg KB: On the mechanical behaviour of intervertebral discs. Spine (Phila Pa 1976). 8:151–165. 1983. View Article : Google Scholar : PubMed/NCBI

Rider SM, Mizuno S and Kang JD: Molecular mechanisms of intervertebral disc degeneration. Spine Surg Relat Res. 3:1–11. 2018. View Article : Google Scholar : PubMed/NCBI

Raj PP: Intervertebral disc: Anatomy-physiology-pathophysiology-treatment. Pain Pract. 8:18–44. 2008. View Article : Google Scholar : PubMed/NCBI

Colombini A, Lombardi G, Corsi MM and Banfi G: Pathophysiology of the human intervertebral disc. Int J Biochem Cell Biol. 40:837–842. 2008. View Article : Google Scholar : PubMed/NCBI

Lyons G, Eisenstein SM and Sweet MB: Biochemical changes in intervertebral disc degeneration. Biochim Biophys Acta. 673:443–453. 1981. View Article : Google Scholar : PubMed/NCBI

Roughley PJ, Melching LI, Heathfield TF, Pearce RH and Mort JS: The structure and degradation of aggrecan in human intervertebral disc. Eur Spine J. 15(Suppl 3): S326–S332. 2006. View Article : Google Scholar : PubMed/NCBI

Binch ALA, Shapiro IM and Risbud MV: Syndecan-4 in intervertebral disc and cartilage: Saint or synner? Matrix Biol. 52-54:355–362. 2016. View Article : Google Scholar : PubMed/NCBI

Xu K, Wang X, Zhang Q, Liang A, Zhu H, Huang D, Li C and Ye W: Sp1 downregulates proinflammatory cytokine-induced catabolic gene expression in nucleus pulposus cells. Mol Med Rep. 14:3961–3968. 2016. View Article : Google Scholar : PubMed/NCBI

Roughley PJ: Biology of intervertebral disc aging and degeneration: Involvement of the extracellular matrix. Spine (Phila Pa 1976). 29:2691–2699. 2004. View Article : Google Scholar : PubMed/NCBI

Sjöberg AP, Manderson GA, Mörgelin M, Day AJ, Heinegård D and Blom AM: Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol. 46:830–839. 2009. View Article : Google Scholar :

Huang YC, Urban JP and Luk KD: Intervertebral disc regeneration: Do nutrients lead the way? Nat Rev Rheumatol. 10:561–566. 2014. View Article : Google Scholar : PubMed/NCBI

Zhang H, Zhu T, Zhang L and Wu Q: Stromal cell-derived factor-1 induces matrix metalloproteinase expression in human endplate chondrocytes, cartilage endplate degradation in explant culture, and the amelioration of nucleus pulposus degeneration in vivo. Int J Mol Med. 41:969–976. 2018.

Hiyama A, Sakai D and Mochida J: Cell signaling pathways related to pain receptors in the degenerated disk. Global Spine J. 3:165–174. 2013. View Article : Google Scholar :

Kondo N, Yuasa T, Shimono K, Tung W, Okabe T, Yasuhara R, Pacifici M, Zhang Y, Iwamoto M and Enomoto-Iwamoto M: Intervertebral disc development is regulated by Wnt/β-catenin signaling. Spine (Phila Pa 1976). 36:E513–E518. 2011. View Article : Google Scholar : PubMed/NCBI

Lotz JC and Ulrich JA: Innervation, inflammation, and hypermobility may characterize pathologic disc degeneration: review of animal model data. J Bone Joint Surg Am. 88(Suppl 2): S76–S82. 2006.

Finkel T and Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature. 408:239–247. 2000. View Article : Google Scholar : PubMed/NCBI

Olovnikov AM: A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 41:181–190. 1973. View Article : Google Scholar : PubMed/NCBI

Stein GH, Beeson M and Gordon L: Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science. 249:666–669. 1990. View Article : Google Scholar : PubMed/NCBI

Feng C, Yang M, Lan M, Liu C, Zhang Y, Huang B, Liu H and Zhou Y: ROS: Crucial intermediators in the pathogenesis of intervertebral disc degeneration. Oxid Med Cell Longev. 2017:56015932017. View Article : Google Scholar : PubMed/NCBI

Dimozi A, Mavrogonatou E, Sklirou A and Kletsas D: Oxidative stress inhibits the proliferation, induces premature senescence and promotes a catabolic phenotype in human nucleus pulposus intervertebral disc cells. Eur Cell Mater. 30:89–103. 2015. View Article : Google Scholar : PubMed/NCBI

Feng C, Liu H, Yang M, Zhang Y, Huang B and Zhou Y: Disc cell senescence in intervertebral disc degeneration: Causes and molecular pathways. Cell Cycle. 15:1674–1684. 2016. View Article : Google Scholar : PubMed/NCBI

Wang D, Hu Z, Hao J, He B, Gan Q, Zhong X, Zhang X, Shen J, Fang J and Jiang W: SIRT1 inhibits apoptosis of degenerative human disc nucleus pulposus cells through activation of Akt pathway. Age (Dordr). 35:1741–1753. 2013. View Article : Google Scholar

Chen JW, Ni BB, Zheng XF, Li B, Jiang SD and Jiang LS: Hypoxia facilitates the survival of nucleus pulposus cells in serum deprivation by down-regulating excessive autophagy through restricting ROS generation. Int J Biochem Cell Biol. 59:1–10. 2015. View Article : Google Scholar

Kim J, Kundu M, Viollet B and Guan KL: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 13:132–141. 2011. View Article : Google Scholar : PubMed/NCBI

Xu HG, Yu YF, Zheng Q, Zhang W, Wang CD, Zhao XY, Tong WX, Wang H, Liu P and Zhang XL: Autophagy protects end plate chondrocytes from intermittent cyclic mechanical tension induced calcification. Bone. 66:232–239. 2014. View Article : Google Scholar : PubMed/NCBI

Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 23:2838–2849. 2004. View Article : Google Scholar : PubMed/NCBI

Deosarkar SD, Arsule AD and Kalyankar TM: Effect of antidiabetic metformin hydrochloride on physicochemical properties of cationic surfactant cetyltrimethylammonium bromide in aqueous solutions. Colloids Surf A: Physicochem Eng Asp. 613:1260522021. View Article : Google Scholar

Dołowy M, Jampilek J and Bober-Majnusz K: A comparative study of the lipophilicity of metformin and phenformin. Molecules. 26:66132021. View Article : Google Scholar :

Ismail AH, Al-Garawi ZS, Al-Shamari K and Salman AT: Metformin compounds: A review on the importance and the possible applications. J Phys Conf Ser. 1853:0120602021. View Article : Google Scholar

He M, Lu B, Opoku M, Zhang L, Xie W, Jin H, Chen S, Li Y and Deng Z: Metformin prevents or delays the development and progression of osteoarthritis: New insight and mechanism of action. Cells. 11:30122022. View Article : Google Scholar : PubMed/NCBI

Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, et al: Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 50:81–98. 2011. View Article : Google Scholar : PubMed/NCBI

Bailey CJ: Metformin: Historical overview. Diabetologia. 60:1566–1576. 2017. View Article : Google Scholar : PubMed/NCBI

He L: Metformin and systemic metabolism. Trends Pharmacol Sci. 41:868–881. 2020. View Article : Google Scholar : PubMed/NCBI

Tucker GT, Casey C, Phillips PJ, Connor H, Ward JD and Woods HF: Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol. 12:235–246. 1981. View Article : Google Scholar : PubMed/NCBI

Wilcock C and Bailey CJ: Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica. 24:49–57. 1994. View Article : Google Scholar : PubMed/NCBI

Sambol NC, Brookes LG, Chiang J, Goodman AM, Lin ET, Liu CY and Benet LZ: Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man. Br J Clin Pharmacol. 42:510–512. 1996. View Article : Google Scholar : PubMed/NCBI

Song Y, Wu Z and Zhao P: The function of metformin in aging-related musculoskeletal disorders. Front Pharmacol. 13:8655242022. View Article : Google Scholar : PubMed/NCBI

Chen S, Ruan G, Zeng M, Chen T, Cao P, Zhang Y, Li J, Wang X, Li S, Tang S, et al: Association between metformin use and risk of total knee arthroplasty and degree of knee pain in knee osteoarthritis patients with diabetes and/or obesity: A retrospective study. J Clin Med. 11:47962022. View Article : Google Scholar : PubMed/NCBI

El-Arabey AA, Abdalla M and Ali Eltayb W: Metformin: Ongoing journey with superdrug revolution. Adv Pharm Bull. 9:1–4. 2019. View Article : Google Scholar : PubMed/NCBI

Mazor M, Best TM, Cesaro A, Lespessailles E and Toumi H: Osteoarthritis biomarker responses and cartilage adaptation to exercise: A review of animal and human models. Scand J Med Sci Sports. 29:1072–1082. 2019. View Article : Google Scholar : PubMed/NCBI

Vinatier C, Merceron C and Guicheux J: Osteoarthritis: From pathogenic mechanisms and recent clinical developments to novel prospective therapeutic options. Drug Discov Today. 21:1932–1937. 2016. View Article : Google Scholar : PubMed/NCBI

Williams S, Alkhatib B and Serra R: Development of the axial skeleton and intervertebral disc. Curr Top Dev Biol. 133:49–90. 2019. View Article : Google Scholar : PubMed/NCBI

Li X, Lee JP, Balian G and Greg Anderson D: Modulation of chondrocytic properties of fat-derived mesenchymal cells in co-cultures with nucleus pulposus. Connect Tissue Res. 46:75–82. 2005. View Article : Google Scholar : PubMed/NCBI

Jørgensen SB, Richter EA and Wojtaszewski JF: Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J Physiol. 574:17–31. 2006. View Article : Google Scholar : PubMed/NCBI

Lee WJ, Kim M, Park HS, Kim HS, Jeon MJ, Oh KS, Koh EH, Won JC, Kim MS, Oh GT, et al: AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun. 340:291–295. 2006. View Article : Google Scholar

Lee-Young RS, Canny BJ, Myers DE and McConell GK: AMPK activation is fiber type specific in human skeletal muscle: effects of exercise and short-term exercise training. J Appl Physiol (1985). 107:283–289. 2009. View Article : Google Scholar : PubMed/NCBI

Bahrambeigi S, Yousefi B, Rahimi M and Shafiei-Irannejad V: Metformin; an old antidiabetic drug with new potentials in bone disorders. Biomed Pharmacother. 109:1593–1601. 2019. View Article : Google Scholar

Qin X, Jiang T, Liu S, Tan J, Wu H, Zheng L and Zhao J: Effect of metformin on ossification and inflammation of fibroblasts in ankylosing spondylitis: An in vitro study. J Cell Biochem. 119:1074–1082. 2018. View Article : Google Scholar

Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, Wu J, Wei X, Qu Q, Yu Y, et al: Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 603:159–165. 2022. View Article : Google Scholar : PubMed/NCBI

Sakamoto K and Jessen N: PEN2: Metformin's new partner at lysosome. Cell Res. 32:507–508. 2022. View Article : Google Scholar : PubMed/NCBI

Liu C, Zhang S, Xue J, Zhang H and Yin J: Evaluation of PEN2-ATP6AP1 axis as an antiparasitic target for metformin based on phylogeny analysis and molecular docking. Mol Biochem Parasitol. 255:1115802023. View Article : Google Scholar : PubMed/NCBI

Dong J, Xu X, Zhang Q, Yuan Z and Tan B: The PI3K/AKT pathway promotes fracture healing through its crosstalk with Wnt/β-catenin. Exp Cell Res. 394:1121372020. View Article : Google Scholar

Watabe H, Furuhama T, Tani-Ishii N and Mikuni-Takagaki Y: Mechanotransduction activates α5β1 integrin and PI3K/Akt signaling pathways in mandibular osteoblasts. Exp Cell Res. 317:2642–2649. 2011. View Article : Google Scholar : PubMed/NCBI

Wang Z, Ma F, Wang J, Zhou Z, Liu B, He X, Fu L, He W and Cooper PR: Extracellular signal-regulated kinase mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling are required for lipopolysaccharide-mediated mineralization in murine odontoblast-like cells. J Endod. 41:871–876. 2015. View Article : Google Scholar : PubMed/NCBI

Tang Y, Mo Y, Xin D, Xiong Z, Zeng L, Luo G and Cao Y: Regulation of osteoblast autophagy based on PI3K/AKT/mTOR signaling pathway study on the effect of β-ecdysterone on fracture healing. J Orthop Surg Res. 16:7192021. View Article : Google Scholar

Lee SH, Lee JH, Lee HY and Min KJ: Sirtuin signaling in cellular senescence and aging. BMB Rep. 52:24–34. 2019. View Article : Google Scholar :

Hu X, Feng G, Meng Z, Ma L and Jin Q: The protective mechanism of SIRT1 on cartilage through regulation of LEF-1. BMC Musculoskelet Disord. 22:6422021. View Article : Google Scholar : PubMed/NCBI

Wang C, Yang Y, Zhang Y, Liu J, Yao Z and Zhang C: Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1/Parkin-dependent mitophagy in primary chondrocytes. Biosci Trends. 12:605–612. 2019. View Article : Google Scholar

Chen Y, Wu YY, Si HB, Lu YR and Shen B: Mechanistic insights into AMPK-SIRT3 positive feedback loop-mediated chondrocyte mitochondrial quality control in osteoarthritis pathogenesis. Pharmacol Res. 166:1054972021. View Article : Google Scholar : PubMed/NCBI

Lin S, Guo H, You X, Zhang Z and Ye H: SND1 aggravates mitochondrial damage, apoptosis and extracellular matrix degradation in IL-1β-stimulated chondrocytes via PINK1/BECN1 pathway. Eur J Med Res. 28:3712023. View Article : Google Scholar

Hu D, Xie F, Xiao Y, Lu C, Zhong J, Huang D, Chen J, Wei J, Jiang Y and Zhong T: Metformin: A potential candidate for targeting aging mechanisms. Aging Dis. 12:480–493. 2021. View Article : Google Scholar : PubMed/NCBI

Xing H, Liang C, Wang C, Xu X, Hu Y and Qiu B: Metformin mitigates cholesterol accumulation via the AMPK/SIRT1 pathway to protect osteoarthritis chondrocytes. Biochem Biophys Res Commun. 632:113–121. 2022. View Article : Google Scholar : PubMed/NCBI

Kang W, Wang T, Hu Z, Liu F, Sun Y and Ge S: Metformin inhibits porphyromonas gingivalis lipopolysaccharide-influenced inflammatory response in human gingival fibroblasts via regulating activating transcription factor-3 expression. J Periodontol. 88:e169–e178. 2017. View Article : Google Scholar : PubMed/NCBI

Saluja M, Pareek KK and Swami YK: Study of diversity of metformin related gastrointestinal side effects. J Assoc Physicians India. 68:36–38. 2020.PubMed/NCBI

Lamos EM, Stein SA and Davis SN: Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother. 13:2545–2554. 2012. View Article : Google Scholar : PubMed/NCBI

Stades AME, Heikens JT, Erkelens DW, Holleman F and Hoekstra JBL: Metformin and lactic acidosis: Cause or coincidence? A review of case reports. J Intern Med. 255:179–187. 2004. View Article : Google Scholar : PubMed/NCBI

Eppenga WL, Lalmohamed A, Geerts AF, Derijks HJ, Wensing M, Egberts A, De Smet PA and de Vries F: Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: A population-based cohort study. Diabetes Care. 37:2218–2224. 2014. View Article : Google Scholar : PubMed/NCBI

O CK, Siu BW, Leung VW, Lin YY, Ding CZ, Lau ES, Luk AO, Chow EY, Ma RC, Chan JC, et al: Association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus: A prospective study of the Hong Kong diabetes register. J Diabetes Complications. 37:1085982023. View Article : Google Scholar : PubMed/NCBI

Wiwanitkit S and Wiwanitkit V: Metformin and sleep disorders. Indian J Endocrinol Metab. 16(Suppl 1): S63–S64. 2012. View Article : Google Scholar : PubMed/NCBI

Rosekind MR and Gregory KB: Insomnia risks and costs: health, safety, and quality of life. Am J Manag Care. 16:617–626. 2010.PubMed/NCBI

Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, et al: Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 23:850–858. 2017. View Article : Google Scholar : PubMed/NCBI

Salvatore T, Pafundi PC, Marfella R, Sardu C, Rinaldi L, Monaco L, Ricozzi C, Imbriani S, Nevola R, Adinolfi LE and Sasso FC: Metformin lactic acidosis: Should we still be afraid? Diabetes Res Clin Pract. 157:1078792019. View Article : Google Scholar : PubMed/NCBI

Rahman F and Tuba S: Lactic acidosis associated with metformin in patients with diabetic kidney disease. Med Arch. 76:297–300. 2022. View Article : Google Scholar : PubMed/NCBI

Hardie DG, Ross FA and Hawley SA: AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 13:251–262. 2012. View Article : Google Scholar : PubMed/NCBI

Du J, Xu M, Kong F, Zhu P, Mao Y, Liu Y, Zhou H, Dong Z, Yu Z, Du T, et al: CB2R attenuates intervertebral disc degeneration by delaying nucleus pulposus cell senescence through AMPK/GSK3β pathway. Aging Dis. 13:552–267. 2022. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Wu J, Teng C, Wang J, Yu J, Jin C, Wang L, Wu L and Lin Z, Yu Z and Lin Z: Orientin downregulating oxidative stress-mediated endoplasmic reticulum stress and mitochondrial dysfunction through AMPK/SIRT1 pathway in rat nucleus pulposus cells in vitro and attenuated intervertebral disc degeneration in vivo. Apoptosis. 27:1031–1048. 2022. View Article : Google Scholar : PubMed/NCBI

Harada M, Tadevosyan A, Qi X, Xiao J, Liu T, Voigt N, Karck M, Kamler M, Kodama I, Murohara T, et al: Atrial fibrillation activates AMP-dependent protein kinase and its regulation of cellular calcium handling: Potential role in metabolic adaptation and prevention of progression. J Am Coll Cardiol. 66:47–58. 2015. View Article : Google Scholar : PubMed/NCBI

Zhang GZ, Deng YJ, Xie QQ, Ren EH, Ma ZJ, He XG, Gao YC and Kang XW: Sirtuins and intervertebral disc degeneration: Roles in inflammation, oxidative stress, and mitochondrial function. Clin Chim Acta. 508:33–42. 2020. View Article : Google Scholar : PubMed/NCBI

Liu Y, Lin J, Wu X, Guo X, Sun H, Yu B, Shen J, Bai J, Chen Z, Yang H, et al: Aspirin-mediated attenuation of intervertebral disc degeneration by ameliorating reactive oxygen species in vivo and in vitro. Oxid Med Cell Longev. 2019:71898542019. View Article : Google Scholar : PubMed/NCBI

Dai X, Chen Y, Yu Z, Liao C, Liu Z, Chen J and Wu Q: Advanced oxidation protein products induce annulus fibrosus cell senescence through a NOX4-dependent, MAPK-mediated pathway and accelerate intervertebral disc degeneration. PeerJ. 10:e138262022. View Article : Google Scholar : PubMed/NCBI

Chen JW, Ni BB, Li B, Yang YH, Jiang SD and Jiang LS: The responses of autophagy and apoptosis to oxidative stress in nucleus pulposus cells: Implications for disc degeneration. Cell Physiol Biochem. 34:1175–1189. 2014. View Article : Google Scholar : PubMed/NCBI

Brennan MÁ, Layrolle P and Mooney DJ: Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration. Adv Funct Mater. 30:19091252020. View Article : Google Scholar : PubMed/NCBI

Varderidou-Minasian S and Lorenowicz MJ: Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: Challenges and opportunities. Theranostics. 10:5979–5997. 2020. View Article : Google Scholar : PubMed/NCBI

Rani S, Ryan AE, Griffin MD and Ritter T: Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications. Mol Ther. 23:812–823. 2015. View Article : Google Scholar : PubMed/NCBI

Latifkar A, Ling L, Hingorani A, Johansen E, Clement A, Zhang X, Hartman J, Fischbach C, Lin H, Cerione RA and Antonyak MA: Loss of sirtuin 1 alters the secretome of breast cancer cells by impairing lysosomal integrity. Dev Cell. 49:393–408.e7. 2019. View Article : Google Scholar : PubMed/NCBI

Minakaki G, Menges S, Kittel A, Emmanouilidou E, Schaeffner I, Barkovits K, Bergmann A, Rockenstein E, Adame A, Marxreiter F, et al: Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 14:98–119. 2018. View Article : Google Scholar :

Wang Y, Xu W, Yan Z, Zhao W, Mi J, Li J and Yan H: Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways. J Exp Clin Cancer Res. 37:632018. View Article : Google Scholar : PubMed/NCBI

Shen M, Yu H, Jin Y, Mo J, Sui J, Qian X and Chen T: Metformin facilitates osteoblastic differentiation and M2 macrophage polarization by PI3K/AKT/mTOR pathway in human umbilical cord mesenchymal stem cells. Stem Cells Int. 2022:94988762022. View Article : Google Scholar : PubMed/NCBI

Han X, Chen H, Gong H, Tang X, Huang N, Xu W, Tai H, Zhang G, Zhao T, Gong C, et al: Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress-induced senescence. J Biol Chem. 295:4451–4463. 2020. View Article : Google Scholar : PubMed/NCBI

Tang Z, Hu B, Zang F, Wang J, Zhang X and Chen H: Nrf2 drives oxidative stress-induced autophagy in nucleus pulposus cells via a Keap1/Nrf2/p62 feedback loop to protect intervertebral disc from degeneration. Cell Death Dis. 10:5102019. View Article : Google Scholar : PubMed/NCBI

Wang J, Huang C, Lin Z, Pan X, Chen J, Zheng G, Tian N, Yan Y, Zhang Z, Hu J, et al: Polydatin suppresses nucleus pulposus cell senescence, promotes matrix homeostasis and attenuates intervertebral disc degeneration in rats. J Cell Mol Med. 22:5720–5731. 2018. View Article : Google Scholar : PubMed/NCBI

Kang L, Zhang H, Jia C, Zhang R and Shen C: Targeting oxidative stress and inflammation in intervertebral disc degeneration: Therapeutic perspectives of phytochemicals. Front Pharmacol. 13:9563552022. View Article : Google Scholar : PubMed/NCBI

Glück S, Guey B, Gulen MF, Wolter K, Kang TW, Schmacke NA, Bridgeman A, Rehwinkel J, Zender L and Ablasser A: Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat Cell Biol. 19:1061–1070. 2017. View Article : Google Scholar : PubMed/NCBI

Cheng Z, Dai T, He X, Zhang Z, Xie F, Wang S, Zhang L and Zhou F: The interactions between cGAS-STING pathway and pathogens. Signal Transduct Target Ther. 5:912020. View Article : Google Scholar : PubMed/NCBI

Chen Q, Sun L and Chen ZJ: Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat Immunol. 17:1142–1149. 2016. View Article : Google Scholar : PubMed/NCBI

Hu MM and Shu HB: Innate immune response to cytoplasmic DNA: Mechanisms and DIseases. Annu Rev Immunol. 38:79–98. 2020. View Article : Google Scholar

Motwani M, Pesiridis S and Fitzgerald KA: DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Genet. 20:657–674. 2019. View Article : Google Scholar : PubMed/NCBI

Kim J, Kim HS and Chung JH: Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp Mol Med. 55:510–519. 2023. View Article : Google Scholar : PubMed/NCBI

Guo Y, Gu R, Gan D, Hu F, Li G and Xu G: Mitochondrial DNA drives noncanonical inflammation activation via cGAS-STING signaling pathway in retinal microvascular endothelial cells. Cell Commun Signal. 18:1722020. View Article : Google Scholar : PubMed/NCBI

Ritchie C, Carozza JA and Li L: Biochemistry, cell biology, and pathophysiology of the innate immune cGAS-cGAMP-STING pathway. Annu Rev Biochem. 91:599–628. 2022. View Article : Google Scholar : PubMed/NCBI

Lawrence T: The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 1:a0016512009. View Article : Google Scholar

Vo NV, Sowa GA, Kang JD, Seidel C and Studer RK: Prostaglandin E2 and prostaglandin F2α differentially modulate matrix metabolism of human nucleus pulposus cells. J Orthop Res. 28:1259–1266. 2010. View Article : Google Scholar : PubMed/NCBI

Tisherman R, Coelho P, Phillibert D, Wang D, Dong Q, Vo N, Kang J and Sowa G: NF-κB signaling pathway in controlling intervertebral disk cell response to inflammatory and mechanical stressors. Phys Ther. 96:704–711. 2016. View Article : Google Scholar : PubMed/NCBI

Ren H, Shao Y, Wu C, Ma X, Lv C and Wang Q: Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway. Mol Cell Endocrinol. 500:1106282020. View Article : Google Scholar

Chen Q, Guan X, Zuo X, Wang J and Yin W: The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases. Acta Pharm Sin B. 6:183–188. 2016. View Article : Google Scholar : PubMed/NCBI

Tang D, Kang R, Van Houten B, Zeh HJ, Billiar TR and Lotze MT: High mobility group box 1 (HMGB1) phenotypic role revealed with stress. Mol Med. 20:359–362. 2014. View Article : Google Scholar : PubMed/NCBI

Leclerc P, Wähämaa H, Idborg H, Jakobsson PJ, Harris HE and Korotkova M: IL-1β/HMGB1 complexes promote The PGE2 biosynthesis pathway in synovial fibroblasts. Scand J Immunol. 77:350–360. 2013. View Article : Google Scholar : PubMed/NCBI

Appavoo E, Hajam IA, Muneeswaran NS, Kondabattula G, Bhanuprakash V and Kishore S: Synergistic effect of high-mobility group box-1 and lipopolysaccharide on cytokine induction in bovine peripheral blood mononuclear cells. Microbiol Immunol. 60:196–202. 2016. View Article : Google Scholar

Wang Y, Che M, Xin J, Zheng Z, Li J and Zhang S: The role of IL-1β and TNF-α in intervertebral disc degeneration. Biomed Pharmacother. 131:1106602020. View Article : Google Scholar

Song Y, Wang Y, Zhang Y, Geng W, Liu W, Gao Y, Li S, Wang K, Wu X, Kang L and Yang C: Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells. J Cell Mol Med. 21:1373–1387. 2017. View Article : Google Scholar : PubMed/NCBI

Dong HC, Li PN, Chen CJ, Xu X, Zhang H, Liu G, Zheng LJ and Li P: Sinomenine attenuates cartilage degeneration by regulating miR-223-3p/NLRP3 inflammasome signaling. Inflammation. 42:1265–1275. 2019. View Article : Google Scholar : PubMed/NCBI

Xu H, Mei Q, Xu B, Liu G and Zhao J: Expression of matrix metalloproteinases is positively related to the severity of disc degeneration and growing age in the East Asian lumbar disc herniation patients. Cell Biochem Biophys. 70:1219–1225. 2014. View Article : Google Scholar : PubMed/NCBI

Vo NV, Hartman RA, Yurube T, Jacobs LJ, Sowa GA and Kang JD: Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. Spine J. 13:331–341. 2013. View Article : Google Scholar : PubMed/NCBI

Liu Q, Jin L, Shen FH, Balian G and Li XJ: Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells-a potential novel treatment for intervertebral disc degeneration. Spine J. 13:1571–1580. 2013. View Article : Google Scholar : PubMed/NCBI

Xian H, Liu Y, Rundberg Nilsson A, Gatchalian R, Crother TR, Tourtellotte WG, Zhang Y, Aleman-Muench GR, Lewis G, Chen W, et al: Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity. 54:1463–1477.e11. 2021. View Article : Google Scholar : PubMed/NCBI

Jiang Y, Xie Z, Yu J and Fu L: Resveratrol inhibits IL-1β-mediated nucleus pulposus cell apoptosis through regulating the PI3K/Akt pathway. Biosci Rep. 39:BSR201900432019. View Article : Google Scholar

Isoda K, Young JL, Zirlik A, MacFarlane LA, Tsuboi N, Gerdes N, Schönbeck U and Libby P: Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol. 26:611–617. 2006. View Article : Google Scholar

Carafa V, Rotili D, Forgione M, Cuomo F, Serretiello E, Hailu GS, Jarho E, Lahtela-Kakkonen M, Mai A and Altucci L: Sirtuin functions and modulation: From chemistry to the clinic. Clin Epigenetics. 8:612016. View Article : Google Scholar : PubMed/NCBI

Dai H, Sinclair DA, Ellis JL and Steegborn C: Sirtuin activators and inhibitors: Promises, achievements, and challenges. Pharmacol Ther. 188:140–154. 2018. View Article : Google Scholar : PubMed/NCBI

Ohguchi K, Itoh T, Akao Y, Inoue H, Nozawa Y and Ito M: SIRT1 modulates expression of matrix metalloproteinases in human dermal fibroblasts. Br J Dermatol. 163:689–694. 2010. View Article : Google Scholar : PubMed/NCBI

Dvir-Ginzberg M, Gagarina V, Lee EJ and Hall DJ: Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J Biol Chem. 283:36300–36310. 2008. View Article : Google Scholar : PubMed/NCBI

Qu L, Yu Y, Qiu L, Yang D, Yan L, Guo J and Jahan R: Sirtuin 1 regulates matrix metalloproteinase-13 expression induced by Porphyromonas endodontalis lipopolysaccharide via targeting nuclear factor-κB in osteoblasts. J Oral Microbiol. 9:13175782017. View Article : Google Scholar

Abdelmawgoud H and El Awady RR: Effect of Sirtuin 1 inhibition on matrix metalloproteinase 2 and Forkhead box O3a expression in breast cancer cells. Genes Dis. 4:240–246. 2017. View Article : Google Scholar

Gagarina V, Gabay O, Dvir-Ginzberg M, Lee EJ, Brady JK, Quon MJ and Hall DJ: SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum. 62:1383–1392. 2010. View Article : Google Scholar : PubMed/NCBI

Song YM, Lee YH, Kim JW, Ham DS, Kang ES, Cha BS, Lee HC and Lee BW: Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. Autophagy. 11:46–59. 2015. View Article : Google Scholar :

Rogacka D, Audzeyenka I, Rychłowski M, Rachubik P, Szrejder M, Angielski S and Piwkowska A: Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK. Biochim Biophys Acta Mol Basis Dis. 1864:115–125. 2018. View Article : Google Scholar

Shen J, Lan Y, Ji Z and Liu H: Sirtuins in intervertebral disc degeneration: Current understanding. Mol Med. 30:442024. View Article : Google Scholar : PubMed/NCBI

Xu J, Shao T, Lou J, Zhang J and Xia C: Aging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration. Front Pharmacol. 14:11729202023. View Article : Google Scholar : PubMed/NCBI

Song Y, Li S, Geng W, Luo R, Liu W, Tu J, Wang K, Kang L, Yin H, Wu X, et al: Sirtuin 3-dependent mitochondrial redox homeostasis protects against AGEs-induced intervertebral disc degeneration. Redox Biol. 19:339–353. 2018. View Article : Google Scholar : PubMed/NCBI

Lin J, Du J, Wu X, Xu C, Liu J, Jiang L, Cheng X, Ge G, Chen L, Pang Q, et al: SIRT3 mitigates intervertebral disc degeneration by delaying oxidative stress-induced senescence of nucleus pulposus cells. J Cell Physiol. 236:6441–6456. 2021. View Article : Google Scholar : PubMed/NCBI

Hu B, Wang P, Zhang S, Liu W, Lv X, Shi D, Zhao L, Liu H, Wang B, Chen S and Shao Z: HSP70 attenuates compression-induced apoptosis of nucleus pulposus cells by suppressing mitochondrial fission via upregulating the expression of SIRT3. Exp Mol Med. 54:309–323. 2022. View Article : Google Scholar : PubMed/NCBI

Zhou TY, Wu YG, Zhang YZ, Bao YW and Zhao Y: SIRT3 retards intervertebral disc degeneration by anti-oxidative stress by activating the SIRT3/FOXO3/SOD2 signaling pathway. Eur Rev Med Pharmacol Sci. 23:9180–9188. 2019.PubMed/NCBI

Karnewar S, Neeli PK, Panuganti D, Kotagiri S, Mallappa S, Jain N, Jerald MK and Kotamraju S: Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction. Biochim Biophys Acta Mol Basis Dis. 1864:1115–1128. 2018. View Article : Google Scholar : PubMed/NCBI

Du Y and Zhang J, Fang F, Wei X, Zhang H, Tan H and Zhang J: Metformin ameliorates hypoxia/reoxygenation-induced cardio-myocyte apoptosis based on the SIRT3 signaling pathway. Gene. 626:182–188. 2017. View Article : Google Scholar : PubMed/NCBI

Chen J, Xie JJ, Jin MY, Gu YT, Wu CC, Guo WJ, Yan YZ, Zhang ZJ, Wang JL, Zhang XL, et al: Sirt6 overexpression suppresses senescence and apoptosis of nucleus pulposus cells by inducing autophagy in a model of intervertebral disc degeneration. Cell Death Dis. 9:562018. View Article : Google Scholar : PubMed/NCBI

Shan L, Wang F, Zhai D, Meng X, Liu J and Lv X: Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomed Pharmacother. 161:1144722023. View Article : Google Scholar : PubMed/NCBI

Valenti MT, Dalle Carbonare L, Zipeto D and Mottes M: Control of the autophagy pathway in osteoarthritis: Key regulators, therapeutic targets and therapeutic strategies. Int J Mol Sci. 22:27002021. View Article : Google Scholar : PubMed/NCBI

Ryter SW, Cloonan SM and Choi AM: Autophagy: A critical regulator of cellular metabolism and homeostasis. Mol Cells. 36:7–16. 2013. View Article : Google Scholar : PubMed/NCBI

Mu W and Wang Z, Ma C, Jiang Y, Zhang N, Hu K, Li L and Wang Z: Metformin promotes the proliferation and differentiation of murine preosteoblast by regulating the expression of sirt6 and oct4. Pharmacol Res. 129:462–474. 2018. View Article : Google Scholar

Yang M, Peng Y, Liu W, Zhou M, Meng Q and Yuan C: Sirtuin 2 expression suppresses oxidative stress and senescence of nucleus pulposus cells through inhibition of the p53/p21 pathway. Biochem Biophys Res Commun. 513:616–622. 2019. View Article : Google Scholar : PubMed/NCBI

Tang X, Chen XF, Wang NY, Wang XM, Liang ST, Zheng W, Lu YB, Zhao X, Hao DL, Zhang ZQ, et al: SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy. Circulation. 136:2051–2067. 2017. View Article : Google Scholar : PubMed/NCBI

Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S and Haque M: Metformin: A review of potential mechanism and therapeutic utility beyond diabetes. Drug Des Devel Ther. 17:1907–1932. 2023. View Article : Google Scholar : PubMed/NCBI

Yanovski JA, Krakoff J, Salaita CG, McDuffie JR, Kozlosky M, Sebring NG, Reynolds JC, Brady SM and Calis KA: Effects of metformin on body weight and body composition in obese insulin-resistant children: A randomized clinical trial. Diabetes. 60:477–485. 2011. View Article : Google Scholar : PubMed/NCBI

Seifarth C, Schehler B and Schneider HJ: Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Exp Clin Endocrinol Diabetes. 121:27–31. 2013.

Piskovatska V, Storey KB, Vaiserman AM and Lushchak O: The use of metformin to increase the human healthspan. Adv Exp Med Biol. 1260:319–332. 2020. View Article : Google Scholar : PubMed/NCBI

Valencia WM, Palacio A, Tamariz L and Florez H: Metformin and ageing: Improving ageing outcomes beyond glycaemic control. Diabetologia. 60:1630–1638. 2017. View Article : Google Scholar : PubMed/NCBI

Espinoza SE, Musi N, Wang CP, Michalek J, Orsak B, Romo T, Powers B, Conde A, Moris M, Bair-Kelps D, et al: Rationale and study design of a randomized clinical trial of metformin to prevent frailty in older adults with prediabetes. J Gerontol A Biol Sci Med Sci. 75:102–109. 2020. View Article : Google Scholar :

Kulkarni AS, Brutsaert EF, Anghel V, Zhang K, Bloomgarden N, Pollak M, Mar JC, Hawkins M, Crandall JP and Barzilai N: Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults. Aging Cell. 17:e127232018. View Article : Google Scholar : PubMed/NCBI

Wang C, Chen B, Feng Q, Nie C and Li T: Clinical perspectives and concerns of metformin as an anti-aging drug. Aging Med (Milton). 3:266–275. 2020. View Article : Google Scholar

World's first anti-aging TAME trial gets green-light-Longevity. Technology. https://www.longevity.technology/worlds-first-anti-aging-trial-gets-green-light/. Accessed July 1, 2020

American Diabetes Association: Erratum: Standards of Care in diabetes-2023 abridged for primary care providers. Clin diabetes. 2023.41:4–31. View Article : Google Scholar

Clin Diabetes. 41:3282023. View Article : Google Scholar

Sun R, Feng J and Wang J: Underlying mechanisms and treatment of cellular senescence-induced biological barrier interruption and related diseases. Aging Dis. 15:612–639. 2024. View Article : Google Scholar :

Zhao JY, Sheng XL, Li CJ, Qin T, He RD, Dai GY, Cao Y, Lu HB, Duan CY and Hu JZ: Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway. Neural Regen Res. 18:1553–1562. 2023. View Article : Google Scholar :

Chen Q, Xie D, Yao Q and Yang L: Effect of metformin on locomotor function recovery in rat spinal cord injury model: A meta-analysis. Oxid Med Cell Longev. 2021:19480032021. View Article : Google Scholar : PubMed/NCBI

Chao-Yang G, Peng C and Hai-Hong Z: Roles of NLRP3 inflammasome in intervertebral disc degeneration. Osteoarthritis Cartilage. 29:793–801. 2021. View Article : Google Scholar : PubMed/NCBI

Vergroesen PP, Kingma I, Emanuel KS, Hoogendoorn RJ, Welting TJ, van Royen BJ, van Dieën JH and Smit TH: Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthritis Cartilage. 23:1057–1070. 2015. View Article : Google Scholar : PubMed/NCBI

Chen WK, Yu XH, Yang W, Wang C, He WS, Yan YG, Zhang J and Wang WJ: lncRNAs: Novel players in intervertebral disc degeneration and osteoarthritis. Cell Prolif. 50:e123132017. View Article : Google Scholar

Fujiwara A, Lim TH, An HS, Tanaka N, Jeon CH, Andersson GB and Haughton VM: The effect of disc degeneration and facet joint osteoarthritis on the segmental flexibility of the lumbar spine. Spine (Phila Pa 1976). 25:3036–3044. 2000. View Article : Google Scholar

Fine N, Lively S, Séguin CA, Perruccio AV, Kapoor M and Rampersaud R: Intervertebral disc degeneration and osteoarthritis: A common molecular disease spectrum. Nat Rev Rheumatol. 19:136–152. 2023. View Article : Google Scholar : PubMed/NCBI

Lyu FJ, Cui H, Pan H, Mc Cheung K, Cao X, Iatridis JC and Zheng Z: Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions. Bone Res. 9:72021. View Article : Google Scholar : PubMed/NCBI

Mojtahedzadeh M, Jafarieh A, Najafi A, Khajavi MR and Khalili N: Comparison of metformin and insulin in the control of hyperglycaemia in non-diabetic critically ill patients. Endokrynol Pol. 63:206–211. 2012.PubMed/NCBI

Farkhondeh T, Amirabadizadeh A, Aramjoo H, Llorens S, Roshanravan B, Saeedi F, Talebi M, Shakibaei M and Samarghandian S: Impact of metformin on cancer biomarkers in non-diabetic cancer patients: A systematic review and meta-analysis of clinical trials. Curr Oncol. 28:1412–1423. 2021. View Article : Google Scholar : PubMed/NCBI

Ko KP, Ma SH, Yang JJ, Hwang Y, Ahn C, Cho YM, Noh DY, Park BJ, Han W and Park SK: Metformin intervention in obese non-diabetic patients with breast cancer: Phase II randomized, double-blind, placebo-controlled trial. Breast Cancer Res Treat. 153:361–370. 2015. View Article : Google Scholar : PubMed/NCBI

Lalau JD, Arnouts P, Sharif A and De Broe ME: Metformin and other antidiabetic agents in renal failure patients. Kidney Int. 87:308–322. 2015. View Article : Google Scholar

Cetin M and Sahin S: Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride. Drug Deliv. 23:2796–2805. 2016. View Article : Google Scholar

Adikwu MU, Yoshikawa Y and Takada K: Bioadhesive delivery of metformin using prosopis gum with antidiabetic potential. Biol Pharm Bull. 26:662–666. 2003. View Article : Google Scholar : PubMed/NCBI

Varde NK and Pack DW: Microspheres for controlled release drug delivery. Expert Opin Biol Ther. 4:35–51. 2004. View Article : Google Scholar

Alexis F, Pridgen EM, Langer R and Farokhzad OC: Nanoparticle technologies for cancer therapy. Handb Exp Pharmacol. 55–86. 2010. View Article : Google Scholar : PubMed/NCBI

Feng Y, Egan B and Wang J: Genetic factors in intervertebral disc degeneration. Genes Dis. 3:178–185. 2016. View Article : Google Scholar : PubMed/NCBI

Cosamalón-Gan I, Cosamalón-Gan T, Mattos-Piaggio G, Villar-Suárez V, García-Cosamalón J and Vega-Álvarez JA: Inflammation in the intervertebral disc herniation. Neurocirugia (Astur : Engl Ed). 32:21–35. 2021.In English, Spanish. View Article : Google Scholar